Growth Metrics

Regenerative Medical Technology (RMTG) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to -$865.0.

  • Regenerative Medical Technology's Other Non Operating Income rose 2921.44% to -$865.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1457.0, marking a year-over-year decrease of 10009.69%. This contributed to the annual value of -$2543.0 for FY2024, which is 10016.83% down from last year.
  • Per Regenerative Medical Technology's latest filing, its Other Non Operating Income stood at -$865.0 for Q3 2025, which was up 2921.44% from -$328.0 recorded in Q2 2025.
  • Regenerative Medical Technology's Other Non Operating Income's 5-year high stood at $3.5 million during Q4 2022, with a 5-year trough of -$2.5 million in Q4 2021.
  • In the last 5 years, Regenerative Medical Technology's Other Non Operating Income had a median value of -$865.0 in 2025 and averaged -$70817.9.
  • Within the past 5 years, the most significant YoY rise in Regenerative Medical Technology's Other Non Operating Income was 23911.09% (2022), while the steepest drop was 38945.65% (2022).
  • Over the past 5 years, Regenerative Medical Technology's Other Non Operating Income (Quarter) stood at -$2.5 million in 2021, then soared by 239.11% to $3.5 million in 2022, then plummeted by 56.54% to $1.5 million in 2023, then tumbled by 99.94% to $885.0 in 2024, then crashed by 197.74% to -$865.0 in 2025.
  • Its Other Non Operating Income was -$865.0 in Q3 2025, compared to -$328.0 in Q2 2025 and -$1149.0 in Q1 2025.